Download presentation
Presentation is loading. Please wait.
1
MANAGEMENT OF PAIN What is pain? How can pain be treated? Cycle-oxygenase inhibitors Opioids
2
“ OPIOID ANALGESICS Narcotics” “Analgesia” = “without pain sensation” Opioids: - reduce pain sensation - reduce concern about pain
3
OPIUM: exudate of seed capsules of Papaver somniferum 10% morphine OPIUM TINCTURE: laudanum, 10% opium, 1% morphine PAREGORIC: camphorated opium tincture, 0.04% morphine
4
Opium poppies in Columbia
5
The milky fluid that oozes from the seed pod of the poppy is opium
6
Various poppy products
7
HISTORY OF OPIOIDS 4000 B.C.Sumerian pictographs of opium poppy 2000 B.C.Use of opium by Greeks 15th Cent.Laudanum used in Europe A.D. 18th Cent.Opium smoking popular in Orient 1803Serturner isolated morphine 1800’sOpium wars in China Civil war in U.S.A. 1900’sHeroin Methadone Meperidine EndorphinsNaloxone
8
OPIATES Morphine Heroin Codeine
9
OPIOID DRUGS Prototype = MORPHINE
11
MORPHINE BASE
12
MORPHINE CNS actions Cardiovascular actions Gastrointestinal actions
13
MORPHINE CNS ACTIONS A.Mechanism: Acts at brain and spinal opioid receptors (especially mu receptors) B.Effects 1.Analgesia-selective 2.Euphoria 3.Drowsiness (coma in overdose) 4.Pituitary: increase PRL and ADH, can decrease ACTH 5.Pupils: miosis 6.Respiratory depression 7.Depression of cough center 8.Stimulation of CTZ, depression of VC 9.Depression on multineuronal reflexes 10.Generalized stimulation (rare) 11.Central cardiovascular, GI actions
15
MORPHINE CARDIOVASCULAR ACTIONS A.Orthostatic hypotension 1.Peripheral vasodilation (?histamine release, inhibition of NE release?) 2.Sympathetic inhibition (CNS) B.Cerebral vasodilation (hypercapnia)
16
MORPHINE GASTROINTESTINAL ACTIONS A.Increased incidence and amplitude of circular muscle contraction B.Decreased gastric emptying C.Decreased transit, constipation D.Spasm of biliary tract, sphincter of Oddi
17
OPIOID DRUGS SITES OF ACTION
18
OPIOID DRUGS Actions
19
OPIOID DRUGS
20
DISPOSITION OF OPIATES ABSORPTION DISTRIBUTION BIOTRANSFORMATION EXCRETION
21
Fig. 1. Effect of route of administration on plasma-free morphine levels. Means S.E. are shown.
23
HAZARDS Respiratory depression GI: nausea, vomiting, constipation Orthostatic hypotension Perceptual disturbance Dependence
26
HEROIN (Diacetylmorphine) 1.Analgesic 2.Penetrates into brain well, potent 3.Hydrolyzed to monoacetylmorphine and to morphine 4.Other pharmacology like morphine
27
Heroin is manufactured in remote “laboratories” using rudimentary equipment
28
Heroin removed from latex balloons prior to being packaged for street sales.
29
Heroin repackaged for sale on the streets of the United States
31
CODEINE (Methylmorphine) 1.Analgesic 2.Effective orally 3.Antitussive 4.Low dependence liability 5.Often stimulatory in overdose 6.Some O-demethylated in vivo
33
MEPERIDINE Shorter duration of action than morphine Not an effective antitussive
34
MEPERIDINE 1.CNS effects a.analgesia b.euphoria c.respiratory depression d.convulsions (normeperidine) e.pupil response variable 2.Smooth muscle a.spasmogenic but not constipating
36
METHADONE 1.CNS effects a.analgesia b.respiratory c.antitussive 2.Other actions a.similar to morphine
37
METHADONE Disposition Well absorbed, orally active Metabolized in liver Long duration of action
39
DEXTROMETHORPHAN Antitussive Not addicting Not analgesic
42
OPIOID ANTAGONISTS Prototype:NALOXONE Naloxone:“pure antagonist” no agonist actions Naloxone:short duration of action
44
OPIOID ANTAGONISTS (Naloxone, naltrexone) $ Competitive antagonists at opioid receptors $ Rapid reversal of opioid agonist effects - analgesia - respiratory depression - miosis $ Do NOT directly antagonize barbiturates, alcohol, benzodiazepines
45
MIXED AGONIST-ANTAGONIST Nalorphine (Nalline) Pentazocine (Talwin) Nalbuphine (Nubain) Butorphanol (Stadol) Buprenorphine (Temgesic) Cyclazocine
46
MIXED OPIOID AGONISTS-ANTAGONISTS 1. NALORPHINE: not used as agonist, replaced by naloxone as antagonist (can induce respiratory depression). 2. PENTAZOCINE Used clinically as agonist Analgesic Euphoria or dysphoria Mild respiratory depression Moderate abuse potential 3. BUTORPHANIL About like pentazocine
50
OPIOID TOLERANCE Cellular tolerance Cross-tolerance with other opioids No cross-tolerance to other drug classes
51
OPIOID DEPENDENCE Users seek euphoria, freedom from anxiety, pleasure Dependence primary psychological physical secondary psychological
52
OPIOID DEPENDENCE Withdrawal syndrome abstinent precipitated with antagonist
53
HEROIN/MORPHINE WITHDRAWAL Early abstinence 8 hrlacrimation, rhinorrhea, yawning, sweating 12 hr“yen” (restless sleep), miserable, dilated pupils, anorexia, gooseflesh, restlessness, irritability, tremor 48 hrsymptoms peak, severe sneezing, yawning, diarrhea, nausea, vomiting, waves of gooseflesh, alternate chills and sweating, weakness, depression, cramps, bone pain, muscle spasm, tachycardia, hypertension, sexual orgasm, dehydration 7 daysacute phase ended Protracted abstinence Weeks, months
54
OVERDOSE Triad Coma Respiratory depression Pinpoint pupils Management Support of vital functions Antidotal therapy Narcotic antagonist
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.